FDA recall D-0008-2026

Dr. Reddy's Laboratories, Inc. · Class II · drug

Product

Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25

Reason for recall

Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.

Distribution

Nationwide within the USA.

Key facts

Status
Ongoing
Initiation date
2025-09-26
Report date
2025-10-15
Voluntary/Mandated
Voluntary: Firm initiated
Location
Princeton, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0008-2026